| Aubree Mcgee, | |
|
3305 Central Park Village Dr Ste 130, Eagan, MN 55121-7707 | |
| (651) 406-8868 | |
| Not Available |
| Full Name | Aubree Mcgee |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 3305 Central Park Village Dr Ste 130, Eagan, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366815060 | NPI | - | NPPES |
| 200615750 A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 1722 (Oklahoma) | Secondary |
| 225XP0200X | Occupational Therapist - Pediatrics | 106594 (Minnesota) | Primary |
| Provider Name | Fairview Express Care |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
A group of scientists has identified a genetic variant that substantially increases the risk for developing schizophrenia in Ashkenazi Jewish and other populations. The study, published by Cell Press on August 5th in the American Journal of Human Genetics, associates a deletion on chromosome 3 with increased incidence of schizophrenia.
Data from two long-term open-label extension studies of Fampridine-SR show that 86.0% of participants remained on therapy after a maximum treatment time of 15 months in study MS-F204EXT, and 69.5% remained on therapy after a maximum treatment time of 36 months in study MS-F203EXT.
"Chief executives of 27 [of the] biggest companies in the U.K., including BP and Vodafone, [on Monday] joined the boss of English football's Premier League in appealing to Prime Minister David Cameron to keep his commitment to devote 0.7 percent of national income on international aid," the Press Trust of India/Business Standard reports (3/11).
An analysis of previous studies indicates that among patients with peripheral artery disease, aspirin use is associated with a statistically nonsignificant decrease in the risk of a group of combined cardiovascular events (nonfatal heart attack, nonfatal stroke, and cardiovascular death), but is associated with a significant reduction in the risk of one of these events, nonfatal stroke, although the findings may be limited by the lack of a large study population, according to an article in the May 13 issue of JAMA, the Journal of the American Medical Association.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aubree Mcgee, 6800 Nw 39th Expy, Bethany, OK 73008-2513 Ph: (405) 440-9866 | Aubree Mcgee, 3305 Central Park Village Dr Ste 130, Eagan, MN 55121-7707 Ph: (651) 406-8868 |
News Archive
A group of scientists has identified a genetic variant that substantially increases the risk for developing schizophrenia in Ashkenazi Jewish and other populations. The study, published by Cell Press on August 5th in the American Journal of Human Genetics, associates a deletion on chromosome 3 with increased incidence of schizophrenia.
Data from two long-term open-label extension studies of Fampridine-SR show that 86.0% of participants remained on therapy after a maximum treatment time of 15 months in study MS-F204EXT, and 69.5% remained on therapy after a maximum treatment time of 36 months in study MS-F203EXT.
"Chief executives of 27 [of the] biggest companies in the U.K., including BP and Vodafone, [on Monday] joined the boss of English football's Premier League in appealing to Prime Minister David Cameron to keep his commitment to devote 0.7 percent of national income on international aid," the Press Trust of India/Business Standard reports (3/11).
An analysis of previous studies indicates that among patients with peripheral artery disease, aspirin use is associated with a statistically nonsignificant decrease in the risk of a group of combined cardiovascular events (nonfatal heart attack, nonfatal stroke, and cardiovascular death), but is associated with a significant reduction in the risk of one of these events, nonfatal stroke, although the findings may be limited by the lack of a large study population, according to an article in the May 13 issue of JAMA, the Journal of the American Medical Association.
› Verified 2 days ago
Colette R Brogan, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 3305 Central Park Village Dr, Eagan, MN 55121 Phone: 651-406-8860 | |
Mrs. Catherine Claire Schwartz, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2795 Pilot Knob Rd, Eagan, MN 55121 Phone: 651-994-9644 | |
Stacey Wiles, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2795 Pilot Knob Rd Ste 100, Eagan, MN 55121 Phone: 651-994-9644 | |
Anne Endrizzi, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2795 Pilot Knob Rd, Suite 100, Eagan, MN 55121 Phone: 651-994-9644 Fax: 651-994-8962 | |
Allison V Mikota, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1185 Town Centre Dr Ste 100, Eagan, MN 55123 Phone: 651-968-5230 Fax: 651-994-5200 | |
Mandy Sans Crainte, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2795 Pilot Knob Rd Ste 100, Eagan, MN 55121 Phone: 651-994-9644 | |
Maureen C Scanlan, OTR/L, CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3294 Rolling Hills Dr, Eagan, MN 55121 Phone: 651-686-7145 |